product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Itk (2F12) Mouse mAb
catalog :
2380
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
2F12
reactivity :
human, mouse, rat
application :
western blot, immunocytochemistry, immunoprecipitation
citations: 4
Published Application/Species/Sample/DilutionReference
  • immunocytochemistry; human; fig s12
Yi J, Manna A, Barr V, Hong J, Neuman K, Samelson L. madSTORM: a superresolution technique for large-scale multiplexing at single-molecule accuracy. Mol Biol Cell. 2016;27:3591-3600 pubmed
  • western blot; mouse; loading ...; fig 5a
Shiheido H, Aoyama T, Takahashi H, Hanaoka K, Abe T, Nishida E, et al. Novel CD3-specific antibody induces immunosuppression via impaired phosphorylation of LAT and PLC?1 following T-cell stimulation. Eur J Immunol. 2014;44:1770-80 pubmed publisher
Postler T, Bixby J, Desrosiers R, Yuste E. Systematic analysis of intracellular trafficking motifs located within the cytoplasmic domain of simian immunodeficiency virus glycoprotein gp41. PLoS ONE. 2014;9:e114753 pubmed publisher
Zhang L, Castanaro C, Luan B, Yang K, Fan L, Fairhurst J, et al. ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models. Mol Cancer Ther. 2014;13:1345-55 pubmed publisher
product information
SKU :
2380S
Product-Name :
Itk (2F12) Mouse mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, (M, R, Mk)
Applications :
Immunoprecipitation
Product-Category :
Immunology and Inflammation
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
72
Host :
Mouse
Target :
Itk
Primary-Protein :
ITK
Alt-Names :
EMT,IL2-inducible T-cell kinase,ITK,Kinase EMT,LYK,MGC126257,MGC126258,PSCTK2,T-cell-specific kinase,Tyrosine-protein kinase ITK/TSK,Tyrosine-protein kinase Lyk,homolog of mouse T-cell itk/tsk
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.